Global Plasma Separation System Market

Plasma Separation System Comprehensive Study by Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In-vitro Diagnostics), Type (Plasma, Red Blood Cells, Platelets, Others), End-user (Research Laboratories & Institutes, Hospitals, Biotechnology & Biopharmaceutical Companies, Others) Players and Region - Global Market Outlook to 2027

Plasma Separation System Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Plasma Separation System Market Overview:
Plasma separation is an approach designed for the separation of blood into plasma and blood cells. In the plasma change (PE) modality, separated plasma is discarded and alternative fluid is infused into the affected person alongside with the blood cells. Blood bag gadget for isolating complete blood into upper, middle, and decrease aspects which can then be remoted from every different in a computerized manner. The device involves a predominant or foremost blood bag having first and 2d outlet ports. The first outlet port communicates by tubing with a first satellite tv for pc bag. The 2nd outlet port communicates by tubing with a 2nd satellite tv for pc bag at one stop and at the different cease communicates with a tubular member extending into and towards the backside of the major bag. In use complete blood is drawn into the primary bag thru an inlet port and centrifuged to shape an upper, much less dense plasma portion, a lower, extra dense pink blood cellphone (RBC) component and an intermediate component of buffy coat (including platelets). Pressure is then utilized to the bag with the first outlet open and the 2nd outlet closed to specific all of the higher plasma thru the first outlet port after which the first outlet port is closed and the 2nd outlet is opened. The decrease RBCs are expressed via stress thru the tubular member and 2nd outlet, leaving solely the intermediate buffy coat in the most important bag. The machine may also be computerized with sensors to reveal and manage the float of fluids thru every outlet and from the essential bag.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • Increasing Prevalence of Various Chronic Diseases, Blood-Related Ailments, and Biopharmaceutical Companies
  • Growing Demand for Source Plasma, Among Other Factor
  • Rise In Demand for Various Blood Components
  • Rising Complexity of Surgical Operations, And an Increase in the Number of Accidents throughout the World

Roadblocks
  • Lack of Knowledge Regarding the Operating Skills of the System
  • Irregular Reimbursement Policies

Opportunities
  • Growing Demand for the Different Component of the Bloods
  • Rapid Advancements in Healthcare
  • Increasing Healthcare Expenditure

Challenges
  • Lack of Skilled Professionals


Competitive Landscape:
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies.
Some of the key players profiled in the report are Terumo BCT (United States), Thermo Fisher Scientific (United States), STEMCELL Technologies (Canada), Philips Healthcare (Netherlands), BD Bioscience (United States), Beckman Coulter (United States), GE Healthcare (United States), Merck Millipore (United States), Fukuda Denshi (Japan) and HEYER Medical (Germany). Additionally, following companies can also be profiled that are part of our coverage like Okuman Medikal Sistemler (Turkey), Autogen Inc (United States), 3F Medical Systems (China) and Lmb Technologie GmbH (Germany). Analyst at AMA Research see United States Players to retain maximum share of Global Plasma Separation System market by 2027. Considering Market by Type, the sub-segment i.e. Plasma will boost the Plasma Separation System market. Considering Market by End-user, the sub-segment i.e. Research Laboratories & Institutes will boost the Plasma Separation System market.

In 2019, Akadeum Life Sciences launched seven new merchandise at the Immunology 2019 Conference in San Diego based totally on the microbubble technology, which makes use of buoyancy to gently separate cells of pastime inside the tube.

What Can be Explored with the Plasma Separation System Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Plasma Separation System Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Plasma Separation System
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Plasma Separation System market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Plasma Separation System market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • In-vitro Diagnostics
By Type
  • Plasma
  • Red Blood Cells
  • Platelets
  • Others

By End-user
  • Research Laboratories & Institutes
  • Hospitals
  • Biotechnology & Biopharmaceutical Companies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Various Chronic Diseases, Blood-Related Ailments, and Biopharmaceutical Companies
      • 3.2.2. Growing Demand for Source Plasma, Among Other Factor
      • 3.2.3. Rise In Demand for Various Blood Components
      • 3.2.4. Rising Complexity of Surgical Operations, And an Increase in the Number of Accidents throughout the World
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Plasma Separation System, by Application, Type, End-user and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Plasma Separation System (Value)
      • 5.2.1. Global Plasma Separation System by: Type (Value)
        • 5.2.1.1. Plasma
        • 5.2.1.2. Red Blood Cells
        • 5.2.1.3. Platelets
        • 5.2.1.4. Others
      • 5.2.2. Global Plasma Separation System by: Application (Value)
        • 5.2.2.1. Biomolecule Isolation
        • 5.2.2.2. Cancer Research
        • 5.2.2.3. Stem Cell Research
        • 5.2.2.4. In-vitro Diagnostics
      • 5.2.3. Global Plasma Separation System by: Type (Value)
        • 5.2.3.1. Plasma
        • 5.2.3.2. Red Blood Cells
        • 5.2.3.3. Platelets
        • 5.2.3.4. Others
      • 5.2.4. Global Plasma Separation System by: End-user (Value)
        • 5.2.4.1. Research Laboratories & Institutes
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Biotechnology & Biopharmaceutical Companies
        • 5.2.4.4. Others
      • 5.2.5. Global Plasma Separation System Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Plasma Separation System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Terumo BCT (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. STEMCELL Technologies (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Philips Healthcare (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BD Bioscience (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Beckman Coulter (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GE Healthcare (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck Millipore (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fukuda Denshi (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HEYER Medical (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Plasma Separation System Sale, by Application, Type, End-user and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Plasma Separation System (Value)
      • 7.2.1. Global Plasma Separation System by: Type (Value)
        • 7.2.1.1. Plasma
        • 7.2.1.2. Red Blood Cells
        • 7.2.1.3. Platelets
        • 7.2.1.4. Others
      • 7.2.2. Global Plasma Separation System by: Application (Value)
        • 7.2.2.1. Biomolecule Isolation
        • 7.2.2.2. Cancer Research
        • 7.2.2.3. Stem Cell Research
        • 7.2.2.4. In-vitro Diagnostics
      • 7.2.3. Global Plasma Separation System by: Type (Value)
        • 7.2.3.1. Plasma
        • 7.2.3.2. Red Blood Cells
        • 7.2.3.3. Platelets
        • 7.2.3.4. Others
      • 7.2.4. Global Plasma Separation System by: End-user (Value)
        • 7.2.4.1. Research Laboratories & Institutes
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Biotechnology & Biopharmaceutical Companies
        • 7.2.4.4. Others
      • 7.2.5. Global Plasma Separation System Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Plasma Separation System: by Type(USD Million)
  • Table 2. Plasma Separation System Plasma , by Region USD Million (2016-2021)
  • Table 3. Plasma Separation System Red Blood Cells , by Region USD Million (2016-2021)
  • Table 4. Plasma Separation System Platelets , by Region USD Million (2016-2021)
  • Table 5. Plasma Separation System Others , by Region USD Million (2016-2021)
  • Table 6. Plasma Separation System: by Application(USD Million)
  • Table 7. Plasma Separation System Biomolecule Isolation , by Region USD Million (2016-2021)
  • Table 8. Plasma Separation System Cancer Research , by Region USD Million (2016-2021)
  • Table 9. Plasma Separation System Stem Cell Research , by Region USD Million (2016-2021)
  • Table 10. Plasma Separation System In-vitro Diagnostics , by Region USD Million (2016-2021)
  • Table 11. Plasma Separation System: by Type(USD Million)
  • Table 12. Plasma Separation System Plasma , by Region USD Million (2016-2021)
  • Table 13. Plasma Separation System Red Blood Cells , by Region USD Million (2016-2021)
  • Table 14. Plasma Separation System Platelets , by Region USD Million (2016-2021)
  • Table 15. Plasma Separation System Others , by Region USD Million (2016-2021)
  • Table 16. Plasma Separation System: by End-user(USD Million)
  • Table 17. Plasma Separation System Research Laboratories & Institutes , by Region USD Million (2016-2021)
  • Table 18. Plasma Separation System Hospitals , by Region USD Million (2016-2021)
  • Table 19. Plasma Separation System Biotechnology & Biopharmaceutical Companies , by Region USD Million (2016-2021)
  • Table 20. Plasma Separation System Others , by Region USD Million (2016-2021)
  • Table 21. South America Plasma Separation System, by Country USD Million (2016-2021)
  • Table 22. South America Plasma Separation System, by Application USD Million (2016-2021)
  • Table 23. South America Plasma Separation System, by Type USD Million (2016-2021)
  • Table 24. South America Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 25. Brazil Plasma Separation System, by Application USD Million (2016-2021)
  • Table 26. Brazil Plasma Separation System, by Type USD Million (2016-2021)
  • Table 27. Brazil Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 28. Argentina Plasma Separation System, by Application USD Million (2016-2021)
  • Table 29. Argentina Plasma Separation System, by Type USD Million (2016-2021)
  • Table 30. Argentina Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 31. Rest of South America Plasma Separation System, by Application USD Million (2016-2021)
  • Table 32. Rest of South America Plasma Separation System, by Type USD Million (2016-2021)
  • Table 33. Rest of South America Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 34. Asia Pacific Plasma Separation System, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Plasma Separation System, by Application USD Million (2016-2021)
  • Table 36. Asia Pacific Plasma Separation System, by Type USD Million (2016-2021)
  • Table 37. Asia Pacific Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 38. China Plasma Separation System, by Application USD Million (2016-2021)
  • Table 39. China Plasma Separation System, by Type USD Million (2016-2021)
  • Table 40. China Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 41. Japan Plasma Separation System, by Application USD Million (2016-2021)
  • Table 42. Japan Plasma Separation System, by Type USD Million (2016-2021)
  • Table 43. Japan Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 44. India Plasma Separation System, by Application USD Million (2016-2021)
  • Table 45. India Plasma Separation System, by Type USD Million (2016-2021)
  • Table 46. India Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 47. South Korea Plasma Separation System, by Application USD Million (2016-2021)
  • Table 48. South Korea Plasma Separation System, by Type USD Million (2016-2021)
  • Table 49. South Korea Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 50. Taiwan Plasma Separation System, by Application USD Million (2016-2021)
  • Table 51. Taiwan Plasma Separation System, by Type USD Million (2016-2021)
  • Table 52. Taiwan Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 53. Australia Plasma Separation System, by Application USD Million (2016-2021)
  • Table 54. Australia Plasma Separation System, by Type USD Million (2016-2021)
  • Table 55. Australia Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Plasma Separation System, by Application USD Million (2016-2021)
  • Table 57. Rest of Asia-Pacific Plasma Separation System, by Type USD Million (2016-2021)
  • Table 58. Rest of Asia-Pacific Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 59. Europe Plasma Separation System, by Country USD Million (2016-2021)
  • Table 60. Europe Plasma Separation System, by Application USD Million (2016-2021)
  • Table 61. Europe Plasma Separation System, by Type USD Million (2016-2021)
  • Table 62. Europe Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 63. Germany Plasma Separation System, by Application USD Million (2016-2021)
  • Table 64. Germany Plasma Separation System, by Type USD Million (2016-2021)
  • Table 65. Germany Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 66. France Plasma Separation System, by Application USD Million (2016-2021)
  • Table 67. France Plasma Separation System, by Type USD Million (2016-2021)
  • Table 68. France Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 69. Italy Plasma Separation System, by Application USD Million (2016-2021)
  • Table 70. Italy Plasma Separation System, by Type USD Million (2016-2021)
  • Table 71. Italy Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 72. United Kingdom Plasma Separation System, by Application USD Million (2016-2021)
  • Table 73. United Kingdom Plasma Separation System, by Type USD Million (2016-2021)
  • Table 74. United Kingdom Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 75. Netherlands Plasma Separation System, by Application USD Million (2016-2021)
  • Table 76. Netherlands Plasma Separation System, by Type USD Million (2016-2021)
  • Table 77. Netherlands Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 78. Rest of Europe Plasma Separation System, by Application USD Million (2016-2021)
  • Table 79. Rest of Europe Plasma Separation System, by Type USD Million (2016-2021)
  • Table 80. Rest of Europe Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 81. MEA Plasma Separation System, by Country USD Million (2016-2021)
  • Table 82. MEA Plasma Separation System, by Application USD Million (2016-2021)
  • Table 83. MEA Plasma Separation System, by Type USD Million (2016-2021)
  • Table 84. MEA Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 85. Middle East Plasma Separation System, by Application USD Million (2016-2021)
  • Table 86. Middle East Plasma Separation System, by Type USD Million (2016-2021)
  • Table 87. Middle East Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 88. Africa Plasma Separation System, by Application USD Million (2016-2021)
  • Table 89. Africa Plasma Separation System, by Type USD Million (2016-2021)
  • Table 90. Africa Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 91. North America Plasma Separation System, by Country USD Million (2016-2021)
  • Table 92. North America Plasma Separation System, by Application USD Million (2016-2021)
  • Table 93. North America Plasma Separation System, by Type USD Million (2016-2021)
  • Table 94. North America Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 95. United States Plasma Separation System, by Application USD Million (2016-2021)
  • Table 96. United States Plasma Separation System, by Type USD Million (2016-2021)
  • Table 97. United States Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 98. Canada Plasma Separation System, by Application USD Million (2016-2021)
  • Table 99. Canada Plasma Separation System, by Type USD Million (2016-2021)
  • Table 100. Canada Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 101. Mexico Plasma Separation System, by Application USD Million (2016-2021)
  • Table 102. Mexico Plasma Separation System, by Type USD Million (2016-2021)
  • Table 103. Mexico Plasma Separation System, by End-user USD Million (2016-2021)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Plasma Separation System: by Type(USD Million)
  • Table 115. Plasma Separation System Plasma , by Region USD Million (2022-2027)
  • Table 116. Plasma Separation System Red Blood Cells , by Region USD Million (2022-2027)
  • Table 117. Plasma Separation System Platelets , by Region USD Million (2022-2027)
  • Table 118. Plasma Separation System Others , by Region USD Million (2022-2027)
  • Table 119. Plasma Separation System: by Application(USD Million)
  • Table 120. Plasma Separation System Biomolecule Isolation , by Region USD Million (2022-2027)
  • Table 121. Plasma Separation System Cancer Research , by Region USD Million (2022-2027)
  • Table 122. Plasma Separation System Stem Cell Research , by Region USD Million (2022-2027)
  • Table 123. Plasma Separation System In-vitro Diagnostics , by Region USD Million (2022-2027)
  • Table 124. Plasma Separation System: by Type(USD Million)
  • Table 125. Plasma Separation System Plasma , by Region USD Million (2022-2027)
  • Table 126. Plasma Separation System Red Blood Cells , by Region USD Million (2022-2027)
  • Table 127. Plasma Separation System Platelets , by Region USD Million (2022-2027)
  • Table 128. Plasma Separation System Others , by Region USD Million (2022-2027)
  • Table 129. Plasma Separation System: by End-user(USD Million)
  • Table 130. Plasma Separation System Research Laboratories & Institutes , by Region USD Million (2022-2027)
  • Table 131. Plasma Separation System Hospitals , by Region USD Million (2022-2027)
  • Table 132. Plasma Separation System Biotechnology & Biopharmaceutical Companies , by Region USD Million (2022-2027)
  • Table 133. Plasma Separation System Others , by Region USD Million (2022-2027)
  • Table 134. South America Plasma Separation System, by Country USD Million (2022-2027)
  • Table 135. South America Plasma Separation System, by Application USD Million (2022-2027)
  • Table 136. South America Plasma Separation System, by Type USD Million (2022-2027)
  • Table 137. South America Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 138. Brazil Plasma Separation System, by Application USD Million (2022-2027)
  • Table 139. Brazil Plasma Separation System, by Type USD Million (2022-2027)
  • Table 140. Brazil Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 141. Argentina Plasma Separation System, by Application USD Million (2022-2027)
  • Table 142. Argentina Plasma Separation System, by Type USD Million (2022-2027)
  • Table 143. Argentina Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 144. Rest of South America Plasma Separation System, by Application USD Million (2022-2027)
  • Table 145. Rest of South America Plasma Separation System, by Type USD Million (2022-2027)
  • Table 146. Rest of South America Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 147. Asia Pacific Plasma Separation System, by Country USD Million (2022-2027)
  • Table 148. Asia Pacific Plasma Separation System, by Application USD Million (2022-2027)
  • Table 149. Asia Pacific Plasma Separation System, by Type USD Million (2022-2027)
  • Table 150. Asia Pacific Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 151. China Plasma Separation System, by Application USD Million (2022-2027)
  • Table 152. China Plasma Separation System, by Type USD Million (2022-2027)
  • Table 153. China Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 154. Japan Plasma Separation System, by Application USD Million (2022-2027)
  • Table 155. Japan Plasma Separation System, by Type USD Million (2022-2027)
  • Table 156. Japan Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 157. India Plasma Separation System, by Application USD Million (2022-2027)
  • Table 158. India Plasma Separation System, by Type USD Million (2022-2027)
  • Table 159. India Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 160. South Korea Plasma Separation System, by Application USD Million (2022-2027)
  • Table 161. South Korea Plasma Separation System, by Type USD Million (2022-2027)
  • Table 162. South Korea Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 163. Taiwan Plasma Separation System, by Application USD Million (2022-2027)
  • Table 164. Taiwan Plasma Separation System, by Type USD Million (2022-2027)
  • Table 165. Taiwan Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 166. Australia Plasma Separation System, by Application USD Million (2022-2027)
  • Table 167. Australia Plasma Separation System, by Type USD Million (2022-2027)
  • Table 168. Australia Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 169. Rest of Asia-Pacific Plasma Separation System, by Application USD Million (2022-2027)
  • Table 170. Rest of Asia-Pacific Plasma Separation System, by Type USD Million (2022-2027)
  • Table 171. Rest of Asia-Pacific Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 172. Europe Plasma Separation System, by Country USD Million (2022-2027)
  • Table 173. Europe Plasma Separation System, by Application USD Million (2022-2027)
  • Table 174. Europe Plasma Separation System, by Type USD Million (2022-2027)
  • Table 175. Europe Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 176. Germany Plasma Separation System, by Application USD Million (2022-2027)
  • Table 177. Germany Plasma Separation System, by Type USD Million (2022-2027)
  • Table 178. Germany Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 179. France Plasma Separation System, by Application USD Million (2022-2027)
  • Table 180. France Plasma Separation System, by Type USD Million (2022-2027)
  • Table 181. France Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 182. Italy Plasma Separation System, by Application USD Million (2022-2027)
  • Table 183. Italy Plasma Separation System, by Type USD Million (2022-2027)
  • Table 184. Italy Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 185. United Kingdom Plasma Separation System, by Application USD Million (2022-2027)
  • Table 186. United Kingdom Plasma Separation System, by Type USD Million (2022-2027)
  • Table 187. United Kingdom Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 188. Netherlands Plasma Separation System, by Application USD Million (2022-2027)
  • Table 189. Netherlands Plasma Separation System, by Type USD Million (2022-2027)
  • Table 190. Netherlands Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 191. Rest of Europe Plasma Separation System, by Application USD Million (2022-2027)
  • Table 192. Rest of Europe Plasma Separation System, by Type USD Million (2022-2027)
  • Table 193. Rest of Europe Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 194. MEA Plasma Separation System, by Country USD Million (2022-2027)
  • Table 195. MEA Plasma Separation System, by Application USD Million (2022-2027)
  • Table 196. MEA Plasma Separation System, by Type USD Million (2022-2027)
  • Table 197. MEA Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 198. Middle East Plasma Separation System, by Application USD Million (2022-2027)
  • Table 199. Middle East Plasma Separation System, by Type USD Million (2022-2027)
  • Table 200. Middle East Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 201. Africa Plasma Separation System, by Application USD Million (2022-2027)
  • Table 202. Africa Plasma Separation System, by Type USD Million (2022-2027)
  • Table 203. Africa Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 204. North America Plasma Separation System, by Country USD Million (2022-2027)
  • Table 205. North America Plasma Separation System, by Application USD Million (2022-2027)
  • Table 206. North America Plasma Separation System, by Type USD Million (2022-2027)
  • Table 207. North America Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 208. United States Plasma Separation System, by Application USD Million (2022-2027)
  • Table 209. United States Plasma Separation System, by Type USD Million (2022-2027)
  • Table 210. United States Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 211. Canada Plasma Separation System, by Application USD Million (2022-2027)
  • Table 212. Canada Plasma Separation System, by Type USD Million (2022-2027)
  • Table 213. Canada Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 214. Mexico Plasma Separation System, by Application USD Million (2022-2027)
  • Table 215. Mexico Plasma Separation System, by Type USD Million (2022-2027)
  • Table 216. Mexico Plasma Separation System, by End-user USD Million (2022-2027)
  • Table 217. Research Programs/Design for This Report
  • Table 218. Key Data Information from Secondary Sources
  • Table 219. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Plasma Separation System: by Type USD Million (2016-2021)
  • Figure 5. Global Plasma Separation System: by Application USD Million (2016-2021)
  • Figure 6. Global Plasma Separation System: by Type USD Million (2016-2021)
  • Figure 7. Global Plasma Separation System: by End-user USD Million (2016-2021)
  • Figure 8. South America Plasma Separation System Share (%), by Country
  • Figure 9. Asia Pacific Plasma Separation System Share (%), by Country
  • Figure 10. Europe Plasma Separation System Share (%), by Country
  • Figure 11. MEA Plasma Separation System Share (%), by Country
  • Figure 12. North America Plasma Separation System Share (%), by Country
  • Figure 13. Global Plasma Separation System share by Players 2021 (%)
  • Figure 14. Global Plasma Separation System share by Players (Top 3) 2021(%)
  • Figure 15. Global Plasma Separation System share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Terumo BCT (United States) Revenue, Net Income and Gross profit
  • Figure 18. Terumo BCT (United States) Revenue: by Geography 2021
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 21. STEMCELL Technologies (Canada) Revenue, Net Income and Gross profit
  • Figure 22. STEMCELL Technologies (Canada) Revenue: by Geography 2021
  • Figure 23. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 24. Philips Healthcare (Netherlands) Revenue: by Geography 2021
  • Figure 25. BD Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 26. BD Bioscience (United States) Revenue: by Geography 2021
  • Figure 27. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 28. Beckman Coulter (United States) Revenue: by Geography 2021
  • Figure 29. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 30. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 31. Merck Millipore (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck Millipore (United States) Revenue: by Geography 2021
  • Figure 33. Fukuda Denshi (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Fukuda Denshi (Japan) Revenue: by Geography 2021
  • Figure 35. HEYER Medical (Germany) Revenue, Net Income and Gross profit
  • Figure 36. HEYER Medical (Germany) Revenue: by Geography 2021
  • Figure 37. Global Plasma Separation System: by Type USD Million (2022-2027)
  • Figure 38. Global Plasma Separation System: by Application USD Million (2022-2027)
  • Figure 39. Global Plasma Separation System: by Type USD Million (2022-2027)
  • Figure 40. Global Plasma Separation System: by End-user USD Million (2022-2027)
  • Figure 41. South America Plasma Separation System Share (%), by Country
  • Figure 42. Asia Pacific Plasma Separation System Share (%), by Country
  • Figure 43. Europe Plasma Separation System Share (%), by Country
  • Figure 44. MEA Plasma Separation System Share (%), by Country
  • Figure 45. North America Plasma Separation System Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Terumo BCT (United States)
  • Thermo Fisher Scientific (United States)
  • STEMCELL Technologies (Canada)
  • Philips Healthcare (Netherlands)
  • BD Bioscience (United States)
  • Beckman Coulter (United States)
  • GE Healthcare (United States)
  • Merck Millipore (United States)
  • Fukuda Denshi (Japan)
  • HEYER Medical (Germany)
Additional players considered in the study are as follows:
Okuman Medikal Sistemler (Turkey) , Autogen Inc (United States) , 3F Medical Systems (China) , Lmb Technologie GmbH (Germany)
Select User Access Type

Key Highlights of Report


Jul 2022 200 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Plasma Separation System Market Quantitative research analysis
Global Plasma Separation System Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Plasma Separation System market are Terumo BCT (United States), Thermo Fisher Scientific (United States), STEMCELL Technologies (Canada), Philips Healthcare (Netherlands), BD Bioscience (United States), Beckman Coulter (United States), GE Healthcare (United States), Merck Millipore (United States), Fukuda Denshi (Japan) and HEYER Medical (Germany), to name a few.
dominated the Plasma Separation System market. This is attributable to growing trend of ""

Know More About Global Plasma Separation System Market Report?

Have a Query? Click Here

Other Related Reports

Skin Implants Comprehensive Study by Implants (Orthopaedic Implants, Cardiovascular Implants, Ocular Implants, Cosmetic Implants, Dental Implants, Others), Operation (Non-Surgical, Surgical), Proce...
$ 3800
Fumigation Service Comprehensive Study by Type (Natural Fumigation, Synthetic Fumigation), Application (Roach, Bed bugs, Flea, Beetles, Other), Industry (Cargo Fumigation, Food processing Fumigation,...
$ 3800
Digital Health Pass Comprehensive Study by Service Channel (Online, Offline), End-User (Hospitals, Clinics), Deployment (Hardware, Software) Players and Region - Global Market Outlook to 2028
$ 3800
Ostomy Care Comprehensive Study by Type (Ostomy bags, Ostomy accessories), End Users (Home Care Settings, Hospitals, Others), Shape (Flat Ostomy Care Products, Convex Ostomy Care Products), Surgery (...
$ 3800
Pet Genetic Test Comprehensive Study by Type (Poultry, Porcine, Bovine, Canine, Other), Service (Genetic Disease Tests, Genetic Trait Tests, DNA Typing, Others), Material (Semen, Embryos) Players and...
$ 3800
Rotator Cuff Injury Therapy Comprehensive Study by Type (Arthroscopic Surgery, Open Surgery, Mini-open Surgery), Application (Hospital, Sport Industry), (), By Treatment (Non-surgical Treatments, Su...
$ 3800